Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma: Results from the phase III GMMG-HD4 and -MM5 trialsElias K. Mai,Marc-A. Baertsch,Thomas Hielscher,Uta Bertsch,Jana Schlenzka,Hans J. Salwender,Markus Munder,Stephan Fuhrmann,Ulrich Duehrsen,Peter Brossart,Kai Neben,Marc S. Raab,Anna Jauch,Anja Seckinger,Dirk Hose,Steffen Luntz,Pieter Sonneveld,Henk Lokhorst,Hans Martin,Hans-Walter Lindemann,Igor Wolfgang Blau,Christof Scheid,Katja Weisel, Mathias Haenel,Jan Duerig,Hartmut GoldschmidtClinical Lymphoma Myeloma and Leukemia（2019）引用 1|浏览78暂无评分关键词bortezomib,Lenalidomide,maintenanceAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
